Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Nuclear hormone receptors, including RXR and PPARγ, represent novel therapeutic targets in melanoma. We have previously shown that the DRO subline of the amelanotic melanoma A375 responds to rexinoid and thiazolidinedione (TZD) treatment in vitro and in vivo. We performed microarray analysis of A375...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Klopper, Joshua P., Sharma, Vibha, Bissonnette, Reid, Haugen, Bryan R.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2763133/
https://ncbi.nlm.nih.gov/pubmed/19859558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/729876
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados